| abstract |
This invention is directed to a novel method and composition for the treatment of diabetes mellitus (Type I, Impaired Glucose Tolerance ['IGT'] and Type II). More specifically, this invention pertains to a novel method and composition for orally treating diabetes mellitus by a dministering to a person afflicted with diabetes mellitus one or more insulin sensitizer chemicals, which increase the cells ability to utilize glucose, together with one or more orally ingested medications for the treatment of diabetes mellitus. A method for the treatment of diabetes mellitus comprising administering to a person with diabetes mellitus a therapeutic amount of an insulin sensitizer with a therapeutic amount of an anti-diabetic agent. |